1. Home
  2. CPIX vs FSEA Comparison

CPIX vs FSEA Comparison

Compare CPIX & FSEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPIX
  • FSEA
  • Stock Information
  • Founded
  • CPIX 1999
  • FSEA 1890
  • Country
  • CPIX United States
  • FSEA United States
  • Employees
  • CPIX N/A
  • FSEA N/A
  • Industry
  • CPIX Biotechnology: Pharmaceutical Preparations
  • FSEA Savings Institutions
  • Sector
  • CPIX Health Care
  • FSEA Finance
  • Exchange
  • CPIX Nasdaq
  • FSEA Nasdaq
  • Market Cap
  • CPIX 37.9M
  • FSEA 43.6M
  • IPO Year
  • CPIX 2009
  • FSEA N/A
  • Fundamental
  • Price
  • CPIX $2.53
  • FSEA $9.96
  • Analyst Decision
  • CPIX
  • FSEA
  • Analyst Count
  • CPIX 0
  • FSEA 0
  • Target Price
  • CPIX N/A
  • FSEA N/A
  • AVG Volume (30 Days)
  • CPIX 509.3K
  • FSEA 5.9K
  • Earning Date
  • CPIX 03-04-2025
  • FSEA 11-08-2024
  • Dividend Yield
  • CPIX N/A
  • FSEA N/A
  • EPS Growth
  • CPIX N/A
  • FSEA N/A
  • EPS
  • CPIX N/A
  • FSEA N/A
  • Revenue
  • CPIX $36,785,442.00
  • FSEA $11,390,000.00
  • Revenue This Year
  • CPIX N/A
  • FSEA N/A
  • Revenue Next Year
  • CPIX N/A
  • FSEA N/A
  • P/E Ratio
  • CPIX N/A
  • FSEA N/A
  • Revenue Growth
  • CPIX N/A
  • FSEA N/A
  • 52 Week Low
  • CPIX $1.04
  • FSEA $8.05
  • 52 Week High
  • CPIX $3.93
  • FSEA $10.38
  • Technical
  • Relative Strength Index (RSI)
  • CPIX 59.45
  • FSEA 55.91
  • Support Level
  • CPIX $2.21
  • FSEA $9.53
  • Resistance Level
  • CPIX $3.93
  • FSEA $10.09
  • Average True Range (ATR)
  • CPIX 0.33
  • FSEA 0.16
  • MACD
  • CPIX -0.00
  • FSEA -0.03
  • Stochastic Oscillator
  • CPIX 20.00
  • FSEA 54.90

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About FSEA First Seacoast Bancorp Inc.

First Seacoast Bancorp Inc is a savings and loan holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one-to-four-family residential real estate loans, commercial real estate, and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. The company generates revenue from financial instruments, such as loans, letters of credit, and investment securities, as well as revenue related to mortgage servicing activities and bank-owned life insurance.

Share on Social Networks: